On ECHEMI
Home > Drugs > Citicoline Sodium for Injection

Citicoline Sodium for Injection

Function and Efficacy

This product is a nucleoside derivative, which promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular structure, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and awakening. The LD50 of intravenous injection for mice, rats and rabbits is 4.15, 3.30, and 1.19/kg respectively.

Ingredients

The main ingredient of this product is citicoline sodium.

Name Description Content CAS NO. Manufacturer
Citicoline sodiumIngredients

This product is a nucleoside derivative, which promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular structure, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and promoting awakening.

More
33818-15-4 13

Appearance

This product is white or off-white loose lumps.

Indication

Coenzyme. Used for acute craniocerebral trauma and postoperative consciousness disorder after craniocerebral surgery.

Usage and Dosage

Intravenous drip: 0.25-0.5 g per day, diluted with 5% or 10% glucose injection and slowly dripped, every 5-10 days as a course of treatment; simple intravenous injection: 100-200 mg each time. Intramuscular injection: 0.1-0.3 g per day, divided into 1-2 injections.

Adverse Reactions

This product has no obvious toxic effects on humans and animals, and has no effect on respiration, pulse and blood pressure. Occasionally, there may be transient blood pressure drop, insomnia, excitement and fever after administration, which will disappear after stopping the drug.

Precautions

Not yet clear

Special Population Medication

Precautions for children: The dosage should be increased or decreased according to the condition and age. Precautions for pregnancy and lactation: No data is available at present. Use with caution in pregnant and lactating women. Precautions for the elderly: The dosage should be increased or decreased according to the condition and age.

Drug Interactions

Not yet clear

Storage

Keep away from light and store in a sealed container.

Packaging Specification

0.25g (according to C14H25N4NaO11P2)

Validity Period

24 months

Manufacturer

Zhejiang Yatai Pharmaceutical Co., Ltd.

  • Founded in:

    2001-12-31
  • Address:

    Room 1501, No. 2003, Qunxian Road, Keqiao District, Shaoxing City, Zhejiang Province
  • Tax NO.:

    91330000146008822C
  • Registered Funds:

    609.17106 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.